EURO MANGANESE INC (EMN.CA) Fundamental Analysis & Valuation

TSX-V:EMN • CA29872T2092

Current stock price

0.15 CAD
0 (0%)
Last:

This EMN.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. EMN.CA Profitability Analysis

1.1 Basic Checks

  • EMN had negative earnings in the past year.
  • EMN had a negative operating cash flow in the past year.
  • EMN had negative earnings in each of the past 5 years.
  • EMN had a negative operating cash flow in each of the past 5 years.
EMN.CA Yearly Net Income VS EBIT VS OCF VS FCFEMN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5M -10M -15M

1.2 Ratios

  • The Return On Assets of EMN (-47.83%) is worse than 63.27% of its industry peers.
Industry RankSector Rank
ROA -47.83%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EMN.CA Yearly ROA, ROE, ROICEMN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for EMN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EMN.CA Yearly Profit, Operating, Gross MarginsEMN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300 -400 -500

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. EMN.CA Health Analysis

2.1 Basic Checks

  • EMN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • EMN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
EMN.CA Yearly Shares OutstandingEMN.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M
EMN.CA Yearly Total Debt VS Total AssetsEMN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M

2.2 Solvency

  • EMN has an Altman-Z score of -5.29. This is a bad value and indicates that EMN is not financially healthy and even has some risk of bankruptcy.
  • EMN has a worse Altman-Z score (-5.29) than 69.94% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.29
ROIC/WACCN/A
WACC12.08%
EMN.CA Yearly LT Debt VS Equity VS FCFEMN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 0.25 indicates that EMN may have some problems paying its short term obligations.
  • With a Current ratio value of 0.25, EMN is not doing good in the industry: 77.86% of the companies in the same industry are doing better.
  • EMN has a Quick Ratio of 0.25. This is a bad value and indicates that EMN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of EMN (0.23) is worse than 77.23% of its industry peers.
Industry RankSector Rank
Current Ratio 0.25
Quick Ratio 0.23
EMN.CA Yearly Current Assets VS Current LiabilitesEMN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. EMN.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 45.02% over the past year.
  • EMN shows a small growth in Revenue. In the last year, the Revenue has grown by 5.66%.
EPS 1Y (TTM)45.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.5%
Revenue 1Y (TTM)5.66%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%10.5%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EMN.CA Yearly Revenue VS EstimatesEMN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 1M 2M 3M 4M
EMN.CA Yearly EPS VS EstimatesEMN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2021 2022 2023 2024 -0.1 -0.2 -0.3

More info and screens

Find the best growth stocksShow best growing peers

0

4. EMN.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for EMN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EMN.CA Price Earnings VS Forward Price EarningsEMN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EMN.CA Per share dataEMN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EMN.CA Dividend Analysis

5.1 Amount

  • EMN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EMN.CA Fundamentals: All Metrics, Ratios and Statistics

EURO MANGANESE INC

TSX-V:EMN (4/14/2026, 7:00:00 PM)

0.15

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-17
Earnings (Next)05-12
Inst Owners17.53%
Inst Owner ChangeN/A
Ins Owners0.86%
Ins Owner ChangeN/A
Market Cap21.44M
Revenue(TTM)4.50M
Net Income(TTM)-16.04M
Analysts40
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.77
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.14
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0.03
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -47.83%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.17%
Cap/Sales 0.93%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.25
Quick Ratio 0.23
Altman-Z -5.29
F-Score5
WACC12.08%
ROIC/WACCN/A
Cap/Depr(3y)368.97%
Cap/Depr(5y)943.59%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.5%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.66%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%10.5%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y20.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y46.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y34.97%
OCF growth 3YN/A
OCF growth 5YN/A

EURO MANGANESE INC / EMN.CA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for EURO MANGANESE INC?

ChartMill assigns a fundamental rating of 0 / 10 to EMN.CA.


Can you provide the valuation status for EURO MANGANESE INC?

ChartMill assigns a valuation rating of 0 / 10 to EURO MANGANESE INC (EMN.CA). This can be considered as Overvalued.


How profitable is EURO MANGANESE INC (EMN.CA) stock?

EURO MANGANESE INC (EMN.CA) has a profitability rating of 0 / 10.


Can you provide the financial health for EMN stock?

The financial health rating of EURO MANGANESE INC (EMN.CA) is 0 / 10.